Screener
Cogent Biosciences, Inc. COGT PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 11,425 | 9,590 |
| Total current assets | 877,803 | 910,355 |
| Operating lease, right-of-use assets | 17,549 | 18,078 |
| Property and equipment, net | 5,298 | 5,457 |
| Restricted cash | 416 | 416 |
| Other assets | 1,940 | 3,301 |
| Total assets | $903,006 | $937,607 |
| Liabilities and Stockholders’ Equity |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cogent Biosciences, Inc.'s PP&E (net)?
- Cogent Biosciences, Inc. (COGT) reported PP&E (net) of $5.3M in Q1 2026.
- How has Cogent Biosciences, Inc.'s PP&E (net) changed year-over-year?
- Cogent Biosciences, Inc.'s PP&E (net) decreased by 17.9% year-over-year, from $6.45M to $5.3M.
- What is the long-term trend for Cogent Biosciences, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s PP&E (net) has grown at a 109.9% compound annual growth rate (CAGR), from $134K to $5.46M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Cogent Biosciences, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude